Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580814 · ClinicalTrials.gov registry record · NA
Brain Dopamine Function in Adults With ADHD
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT00580814 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 75 participants.
The verdict
NCT00580814, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate the functional state of dopamine cells and the dopamine transporter in ADHD subjects and controls to assess the effects of chronic methylphenidate treatment on dopamine cell function and dopamine transporter levels in ADHD subjects.
Interventions
- DRUG Experimental: methylphenidate treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00580814
The ClinicalTrials.gov registry entry for NCT00580814 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Experimental: methylphenidate treatment is the first listed.
NCT00580814 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00580814 about?
NCT00580814 is a clinical study titled "Brain Dopamine Function in Adults With ADHD". The purpose of the study is to investigate the functional state of dopamine cells and the dopamine transporter in ADHD subjects and controls to assess the effects of chronic methylphenidate treatment on dopamine cell function and dopamine transporter levels in ADHD subjects.
What is the current status of trial NCT00580814?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2006-02. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00580814?
The interventions under investigation include: Experimental: methylphenidate treatment (DRUG).
Who is sponsoring clinical trial NCT00580814?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.